Depreciation of Protara Therapeutics, Inc. from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Protara Therapeutics, Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • Protara Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2025 was $83,000, unchanged year-over-year.
  • Protara Therapeutics, Inc. annual Depreciation for 2025 was $362,000, a 9% increase from 2024.
  • Protara Therapeutics, Inc. annual Depreciation for 2024 was $332,000, a 2.6% decline from 2023.
  • Protara Therapeutics, Inc. annual Depreciation for 2023 was $341,000, a 38% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Protara Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $362,000 +$30,000 +9% 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $332,000 -$9,000 -2.6% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $341,000 +$93,000 +38% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2025 2024 FY
2022 $248,000 +$131,000 +112% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024 2023 FY
2021 $117,000 +$14,000 +14% 01 Jan 2021 31 Dec 2021 10-K 08 Mar 2023 2022 FY
2020 $103,000 +$87,000 +544% 01 Jan 2020 31 Dec 2020 10-K 09 Mar 2022 2021 FY
2019 $16,000 -$99,000 -86% 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2021 2020 FY
2018 $115,000 -$33,000 -22% 01 Jan 2018 31 Dec 2018 10-K 20 Mar 2020 2019 FY
2017 $148,000 +$25,000 +20% 01 Jan 2017 31 Dec 2017 10-K 13 Mar 2019 2018 FY
2016 $123,000 +$66,000 +116% 01 Jan 2016 31 Dec 2016 10-K 13 Mar 2019 2018 FY
2015 $57,000 01 Jan 2015 31 Dec 2015 10-K 14 Mar 2018 2017 FY

Protara Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $83,000 $0 0% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $83,000 +$6,000 +7.8% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $77,000 +$21,000 +38% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q1 2022 $56,000 +$24,000 +75% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $32,000 -$18,000 -36% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $108,000 $50,000 -$124,000 -71% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q4 2019 $16,000 $279,000 -$311,000 -972% 01 Oct 2019 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 $327,000 $100,000 +$78,000 +355% 01 Jul 2019 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $249,000 $21,000 -$8,000 -28% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $257,000 $174,000 +$142,000 +444% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $115,000 $32,000 01 Oct 2018 31 Dec 2018 10-K 20 Mar 2020 2019 FY
Q3 2018 $22,000 01 Jul 2018 30 Sep 2018 10-Q 31 Oct 2019 2019 Q3
Q2 2018 $29,000 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $32,000 -$8,000 -20% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $40,000 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.